Author = Hghiralsadat, Bibi Fatemeh
Synergistic co-administration of doxorubicin and berberine by PLGA/PVA hybrid polymeric Nanoformulation for breast cancer treatment

Articles in Press, Accepted Manuscript, Available Online from 14 August 2024

10.22038/nmj.2024.79160.1945

Masoumeh Rahmani; Mahdieh Hemati; Milad Akhlaghi; Bibi Fatemeh Haghiralsadat; Fatemeh Oroojalian


Synthesis of nano-liposomes containing Mentha piperita essential oil and investigating their stability, antimicrobial, antioxidant, and antiproliferative properties

Volume 12, Issue 1, January 2025, Pages 122-139

10.22038/nmj.2024.79435.1960

Mohammad Majdizadeh; Sanaz Akbarzadeh; Hussein H Al-Turnachy; Mahdie Hemati; Milad Akhlaghi; Bibi Fatemeh Haghiralsadat; Fatemeh Oroojalian


Investigation and comparison of laser and ultrasound effects on the temperature increasing of the solutions containing graphene oxide nanoparticles for thermal treatment of osteosarcoma cancer cells

Volume 10, Issue 4, October 2023, Pages 313-322

10.22038/nmj.2023.74019.1802

Najmeh Sadat Hosseini Motlagh; Elyas Sharifi; Bibi Fatemeh Hghiralsadat; Mohsen Sardari Zarchi; Fatemeh Yaghoubi; Fatemeh Oroojalian


Synthesis of a stimuli-sensitive PEGylated nanoniosomal doxorubicin for the treatment of acute myeloid leukemia: An in vitro study

Volume 10, Issue 1, January 2023, Pages 77-84

10.22038/nmj.2022.69777.1745

Fatemeh Bahrami-Banan; Mohammad Hasan Sheikhha; Nasrin Ghasemi; Masoumeh Rahmani; Mahdie Hemati; Mohammadreza Safdari; Fatemeh Haghiralsadat


In vitro evaluation and comparison of anticancer, antimicrobial, and antifungal properties of thyme niosomes containing essential oil

Volume 9, Issue 4, October 2022, Pages 307-318

10.22038/nmj.2022.66932.1707

Marzieh Ebrahimpour; Milad Akhlaghi; Mahdie Hemati; Samereh Ghazanfary; Shayesteh Shahriary; Sina Jafari Ghalekohneh; Sanaz Raeisi; Davood Tofighi; Bibi Fatemeh Haghiralsadat; Fatemeh Oroojalian


Synthesis, physicochemical characterization and pharmaceutical function of niosomal nanoparticles-encapsulated bioactive compound for osteosarcoma treatment

Volume 9, Issue 3, July 2022, Pages 205-215

10.22038/nmj.2022.63770.1665

Mohammad Taebpour; Milad Akhlaghi; Shayesteh Shahriyari; Saeedeh Hajihosseini; Bibi Fatemeh Haghiralsadat; Fatemeh Oroojalian; Davood Tofighi